HCA Red Flag: Demant leaves guidance unchanged, while analysts are above the midpoint (AI)
HC Andersen Capital
Summary
- Demant's unchanged guidance for operating profit, with a midpoint of DKK 4.85 billion, falls below analyst expectations of DKK 4.94 billion, indicating a slightly weaker outlook despite a 27% share price increase over three months.
- The company anticipates a slowdown in Q4, with guidance suggesting a maximum growth of 8%, as competitors launch new products, following a Q3 market growth of 7%.
- The hearing aid market saw a 7% value growth in Q3, driven by an 8% unit sales increase in the US private market, potentially raising the baseline for 2027.
- Strong cash flows have significantly reduced Demant's net gearing from 3.0 in Q2, facilitating a planned buyback of at least DKK 3 billion.
This content is generated by AI. You can give feedback on it in the Inderes forum.
Automatic translation: Originally published in Danish 03/11/2026, 16:43 GMT. Give feedback here.
Red Flag · First read of the report · AI-generated content
HCA Red Flag: Demant leaves guidance unchanged, while analysts are above the midpoint (AI)
Demant (DEMANT) · Q3 2026 · November 3
Share up 27% in 3 months, 1% below 52-week high
| Overall assessment | Slightly negative assessment |
| Positive assessment | Balanced | Negative assessment |
An unchanged guidance for operating profit with a midpoint of DKK 4.85 billion vs. the expected DKK 4.94 billion points to a slightly weaker opening, because nothing new lifts estimates following the 27% share price increase. The market grew by 7% in Q3, which keeps the top end of the guidance within reach.
Red flags in the report
Guidance midpoint lies below analyst estimates
Unchanged: DKK 4,700 to 5,000 million – Est. DKK 4,939 million
Demant reiterated the range for EBIT before special items – i.e., operating profit before one-off costs – leaving the midpoint DKK 89 million below analyst expectations. Without a narrowing toward the top end, estimates receive no new boost.
Demant expects a slowdown itself in Q4
Guidance: 7 to 8% – After 9 mos.: 8% – Q3: 11%
Launches late in the quarter accounted for, according to Demant, of around 1 percentage point of the market's unit growth of 6%, and the top end of the guidance implies a maximum of around 8% in Q4. Management expects lower growth as competitors launch new products.
The share price increase has anticipated the strong quarter
+27% in 3 mos. · C25: +9%
The share rose by 27% in three months vs. 9% for the C25 index, of which 6% came on the day the quarterly sales figures were released on October 9. Without new figures, the share price lacks a reason to rise.
Green flags in the report
The market grew by 7%, and the US bounced back
Q3: ~7% in value · US private: 8% in units
The hearing aid market grew by ~7% in value in Q3, driven by the private market in the US, where unit sales rose by 8% following 0% in Q2. If the improvement holds, it raises the baseline for 2027.
Gross margin increased more than Demant itself expected
No figure disclosed · Of which tariff refund: DKK 25 million
Higher average prices for the new Oticon Reveal and the KIND hearing clinic chain lifted the gross margin – what remains of each sales krone after production. This points toward the top end of the guidance, but the figure will only be released with the annual report.
Strong cash flows significantly decreased the leverage from 3.0
Net gearing: down from 3.0 in Q2 · Target: 2.0 to 2.5
Very strong cash flows from operations caused net debt relative to EBITDA to fall significantly from 3.0 in Q2. This makes the buyback of at least DKK 3 billion easier to finance.
Disclaimer: This is an HCA AI-generated research commentary based solely on the company's published financial report. The commentary does not constitute investment consulting and should not be used as the sole basis for investment decisions. Investing in shares involves the risk of loss. Seek professional consulting. / HC Andersen Capital, 5:42 PM, November 3, 2026
Login required
This content is only available for logged in users